US Patent Issued to Gannex Pharma on April 14 for "Compounds for modulating activity of FXR and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,716, issued on April 14, was assigned to Gannex Pharma Co. Ltd. (Shanghai).

"Compounds for modulating activity of FXR and uses thereof" was invented by Bailing Yang (Shanghai), Gudmundsson Kristjan (Shanghai), Liuyu Dong (Shanghai) and James Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound for modulating the activity of FXR having a structure of formula (I), a pharmaceutically acceptable salt, an ester or a stereoisomer thereof."

The patent was filed on Oct. 12, 2020, under Application No. 17/756,789.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/np...